The diagnosis of neonatal diabetes in a mother at 25 years of age

Diabetes Care

Volumn 35, Issue 8, 2012, Pages

  Khurana, Divya ^a   Contreras, Maria ^a   Malhotra, Neha ^a   Bargman, Renee ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

AMINO ACID SUBSTITUTION; CASE REPORT; CODON; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KCNJ11 GENE; LETTER; MUTATOR GENE; NEWBORN; NEWBORN DIABETES MELLITUS;

ADULT; DIABETES MELLITUS; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MOTHERS;

EID: 84864386821     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2439     Document Type: Letter

References (4)

1. LaRoith D, Olesfsky JM, Taylor SI. Diabetes Mellitus: A Fundamental and Clinical Text. 3rd Ed. Philadelphia, PA, Lippincott Williams & Wilkins; 2004
2. Pearson ER, Flechtner I, Njølstad PR, et al.; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355:467-477 (Pubitemid 44162274)
3. Aguilar-Bryan L, Bryan J. Neonatal diabetes mellitus. Endocr Rev 2008;29:265-291 (Pubitemid 351679699)
4. Iafusco D, Stazi MA, Cotichini R, et al.; Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Permanent diabetes mellitus in the first year of life. Diabetologia 2002;45:798-804